» Articles » PMID: 39069558

Helical Superstructures Between Amyloid and Collagen in Cardiac Fibrils from a Patient with AL Amyloidosis

Abstract

Systemic light chain (LC) amyloidosis (AL) is a disease where organs are damaged by an overload of a misfolded patient-specific antibody-derived LC, secreted by an abnormal B cell clone. The high LC concentration in the blood leads to amyloid deposition at organ sites. Indeed, cryogenic electron microscopy (cryo-EM) has revealed unique amyloid folds for heart-derived fibrils taken from different patients. Here, we present the cryo-EM structure of heart-derived AL amyloid (AL59) from another patient with severe cardiac involvement. The double-layered structure displays a u-shaped core that is closed by a β-arc lid and extended by a straight tail. Noteworthy, the fibril harbours an extended constant domain fragment, thus ruling out the variable domain as sole amyloid building block. Surprisingly, the fibrils were abundantly concatenated with a proteinaceous polymer, here identified as collagen VI (COLVI) by immuno-electron microscopy (IEM) and mass-spectrometry. Cryogenic electron tomography (cryo-ET) showed how COLVI wraps around the amyloid forming a helical superstructure, likely stabilizing and protecting the fibrils from clearance. Thus, here we report structural evidence of interactions between amyloid and collagen, potentially signifying a distinct pathophysiological mechanism of amyloid deposits.

Citing Articles

A conformational fingerprint for amyloidogenic light chains.

Paissoni C, Puri S, Broggini L, Sriramoju M, Maritan M, Russo R Elife. 2025; 13.

PMID: 40028903 PMC: 11875538. DOI: 10.7554/eLife.102002.


Serum Amyloid A Binding to Glycosaminoglycans is Synergistic with Amyloid Formation: Therapeutic Targeting in the Inflammation-linked Amyloidosis.

Jayaraman S, Urdaneta A, Fandrich M, Gursky O J Mol Biol. 2025; 437(8):169007.

PMID: 39954777 PMC: 11903164. DOI: 10.1016/j.jmb.2025.169007.


Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis.

Morgan G, Yung Z, Spencer B, Sanchorawala V, Prokaeva T Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598451 PMC: 11597191. DOI: 10.3390/ph17111542.


Conformational Differences in the Light Chain Constant Domain of Immunoglobulin G and Free Light Chain May Influence Proteolysis in AL Amyloidosis.

Klimtchuk E, Prokaeva T, Spencer B, Wong S, Ghosh S, Urdaneta A J Mol Biol. 2024; 436(23):168837.

PMID: 39490919 PMC: 11636358. DOI: 10.1016/j.jmb.2024.168837.


Molecular basis for non-invasive diagnostics of cardiac amyloids using bone tracers.

Lewkowicz E, Jayaraman S, Gursky O Biomater Sci. 2024; 12(17):4275-4282.

PMID: 39046441 PMC: 11334954. DOI: 10.1039/d4bm00816b.

References
1.
Del Pozo-Yauner L, Herrera G, Perez Carreon J, Turbat-Herrera E, Rodriguez-Alvarez F, Ruiz Zamora R . Role of the mechanisms for antibody repertoire diversification in monoclonal light chain deposition disorders: when a friend becomes foe. Front Immunol. 2023; 14:1203425. PMC: 10374031. DOI: 10.3389/fimmu.2023.1203425. View

2.
Bodi K, Prokaeva T, Spencer B, Eberhard M, Connors L, Seldin D . AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid. 2009; 16(1):1-8. PMC: 4123194. DOI: 10.1080/13506120802676781. View

3.
Perfetti V, Palladini G, Casarini S, Navazza V, Rognoni P, Obici L . The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44. Blood. 2011; 119(1):144-50. DOI: 10.1182/blood-2011-05-355784. View

4.
Prokaeva T, Spencer B, Kaut M, Ozonoff A, Doros G, Connors L . Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum. 2007; 56(11):3858-68. DOI: 10.1002/art.22959. View

5.
Abraham R, Geyer S, Price-Troska T, Allmer C, Kyle R, Gertz M . Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood. 2003; 101(10):3801-8. DOI: 10.1182/blood-2002-09-2707. View